SINGAPORE (Dec 13): While Israel-based The Trendlines Group sank into losses for 3QFY2019, its latest quarter, the company expects to be better positioned — with more resources, and time to grow the value of its portfolio of investments, following an investment by a new significant shareholder hailing from Iran.
An early-stage investment company, Trendlines focuses on enterprises with innovative technologies for use in the medical and agricultural industries. The company has a portfolio of some 50 companies in Israel, China and Singapore.
The company says it has raised more US$75 million ($101.8 million) in funding, excluding government grants, since it started in 2017. It also has a Singapore-based medical technology start-up incubator called Trendlines Medical Singapore, which it established with German medical device company B.Braun at end-2016.
